News Amgen's Repatha gets EU cardio risk reduction label But Sanofi/Regeneron could have advantage thanks to price cut and better data
News Sanofi invests in new Canadian vaccine manufacturing plant Sanofi is investing 350 million euros in a new vaccine manufacturing facility at its Canadian headquarters in Toronto.
News Sanofi/Lexicon's sotagliflozin filed in US and EU for type 1... Regulators in the US and Europe are to review Sanofi/Lexicon’s sotagliflozin in type 1 diabetes, a potential blockbuster pill.
News Ablynx drug fails in mid-stage lupus trial Ablynx’s vobarilizumab has failed in a mid-stage trial in lupus, with the biotech’s multi-billion buyout from Sanofi just around the corner.
Partner Content Partner Content Sanofi Joins the Speaker Line-up for SMi's Launch, Injectabl... Injectable Drug Delivery
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
